These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

935 related articles for article (PubMed ID: 19400705)

  • 21. Phosphoproteomics by mass spectrometry and classical protein chemistry approaches.
    Salih E
    Mass Spectrom Rev; 2005; 24(6):828-46. PubMed ID: 15538747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From raw data to biological discoveries: a computational analysis pipeline for mass spectrometry-based proteomics.
    Lavallée-Adam M; Park SK; Martínez-Bartolomé S; He L; Yates JR
    J Am Soc Mass Spectrom; 2015 Nov; 26(11):1820-6. PubMed ID: 26002791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry.
    Vanrobaeys F; Van Coster R; Dhondt G; Devreese B; Van Beeumen J
    J Proteome Res; 2005; 4(6):2283-93. PubMed ID: 16335977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robust enrichment of phosphorylated species in complex mixtures by sequential protein and peptide metal-affinity chromatography and analysis by tandem mass spectrometry.
    Collins MO; Yu L; Husi H; Blackstock WP; Choudhary JS; Grant SG
    Sci STKE; 2005 Aug; 2005(298):pl6. PubMed ID: 16118397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent developments in proteome informatics for mass spectrometry analysis.
    Wright JC; Hubbard SJ
    Comb Chem High Throughput Screen; 2009 Feb; 12(2):194-202. PubMed ID: 19199887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LC-MALDI-TOF/TOF for shotgun proteomics.
    Fernández-Puente P; Mateos J; Blanco FJ; Ruiz-Romero C
    Methods Mol Biol; 2014; 1156():27-38. PubMed ID: 24791979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large-scale protein identification using mass spectrometry.
    Lin D; Tabb DL; Yates JR
    Biochim Biophys Acta; 2003 Mar; 1646(1-2):1-10. PubMed ID: 12637006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioinformatic methods to exploit mass spectrometric data for proteomic applications.
    Chalkley RJ; Hansen KC; Baldwin MA
    Methods Enzymol; 2005; 402():289-312. PubMed ID: 16401513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphoproteomics of human platelets: A quest for novel activation pathways.
    Zahedi RP; Begonja AJ; Gambaryan S; Sickmann A
    Biochim Biophys Acta; 2006 Dec; 1764(12):1963-76. PubMed ID: 17049321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catch me if you can: mass spectrometry-based phosphoproteomics and quantification strategies.
    Eyrich B; Sickmann A; Zahedi RP
    Proteomics; 2011 Feb; 11(4):554-70. PubMed ID: 21226000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased confidence in large-scale phosphoproteomics data by complementary mass spectrometric techniques and matching of phosphopeptide data sets.
    Alcolea MP; Kleiner O; Cutillas PR
    J Proteome Res; 2009 Aug; 8(8):3808-15. PubMed ID: 19537829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass spectrometry technologies for proteomics.
    Cañas B; López-Ferrer D; Ramos-Fernández A; Camafeita E; Calvo E
    Brief Funct Genomic Proteomic; 2006 Feb; 4(4):295-320. PubMed ID: 17202122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel multidimensional protein identification technology approach combining protein size exclusion prefractionation, peptide zwitterion-ion hydrophilic interaction chromatography, and nano-ultraperformance RP chromatography/nESI-MS2 for the in-depth analysis of the serum proteome and phosphoproteome: application to clinical sera derived from humans with benign prostate hyperplasia.
    Garbis SD; Roumeliotis TI; Tyritzis SI; Zorpas KM; Pavlakis K; Constantinides CA
    Anal Chem; 2011 Feb; 83(3):708-18. PubMed ID: 21174401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics.
    Batth TS; Francavilla C; Olsen JV
    J Proteome Res; 2014 Dec; 13(12):6176-86. PubMed ID: 25338131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass spectrometry-based proteomics in the life sciences.
    Lane CS
    Cell Mol Life Sci; 2005 Apr; 62(7-8):848-69. PubMed ID: 15868409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parallel Channels-Multidimensional Protein Identification Technology.
    Zhang N; Liu X; Gao S; Wong CC
    J Am Soc Mass Spectrom; 2020 Jul; 31(7):1440-1447. PubMed ID: 32310654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An integrated chemical, mass spectrometric and computational strategy for (quantitative) phosphoproteomics: application to Drosophila melanogaster Kc167 cells.
    Bodenmiller B; Mueller LN; Pedrioli PG; Pflieger D; Jünger MA; Eng JK; Aebersold R; Tao WA
    Mol Biosyst; 2007 Apr; 3(4):275-86. PubMed ID: 17372656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantify this! Report on a round table discussion on quantitative mass spectrometry in proteomics.
    Quadroni M; Ducret A; Stöcklin R
    Proteomics; 2004 Aug; 4(8):2211-5. PubMed ID: 15274113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative phosphoproteomics to characterize signaling networks.
    Rigbolt KT; Blagoev B
    Semin Cell Dev Biol; 2012 Oct; 23(8):863-71. PubMed ID: 22677334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.